Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.

@article{Obrien1994CosteffectivenessOE,
  title={Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.},
  author={Bernie J O'brien and David R Anderson and Ron Goeree},
  journal={CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year={1994},
  volume={150 7},
  pages={1083-90}
}
OBJECTIVE To compare the efficacy and cost-effectiveness of enoxaparin, a low-molecular-weight heparin derivative, with that of low-dose warfarin in the prevention of deep-vein thrombosis (DVT) after total hip replacement. DATA SOURCES English-language articles on enoxaparin and warfarin prophylaxis is patients undergoing total hip replacement published from January 1982 to December 1992. STUDY SELECTION Four trials of enoxaparin (involving 567 patients) and six trials of warfarin… CONTINUE READING